Previous Article | Next Article ![]()
Infection and Immunity, March 2000, p. 1529-1534, Vol. 68, No. 3
National Institute of Child Health and Human Development,
National Institutes of Health, Bethesda, Maryland
20892-2720,1 and Huu Nghi Hospital,
Cao Lânh District, Dong Thap Province,2
Pasteur Institut, Ho Chi Minh City,3
and National Institute of Hygiene and Epidemiology,
Hanoi,4 Vietnam
Received 23 July 1999/Returned for modification 27 October
1999/Accepted 26 November 1999
Salmonella enterica serovar Paratyphi A O-specific
polysaccharide (O-SP) was activated with
1-cyano-4-dimethylaminopyridinium tetrafluoroborate (CDAP) and bound to
tetanus toxoid (TT) with adipic acid dihydrazide as a linker
(SPA-TT1) or directly (SPA-TT2). In mice, these
two conjugates elicited high levels of immunoglobulin G (IgG)
anti-lipopolysaccharide (LPS) in serum with bactericidal activity (E. Konadu, J. Shiloach, D. A. Bryla, J. B. Robbins, and S. C. Szu, Infect.
Immun. 64:2709-2715, 1996). The safety and immunogenicity of the two
conjugates were then evaluated sequentially in Vietnamese adults,
teenagers, and 2- to 4-year-old children. None of the vaccinees
experienced significant side effects, and all had preexisting LPS
antibodies. At 4 weeks after injection, there were significant
increases of the geometric mean IgG and IgM anti-LPS levels in the
adults and teenagers: both conjugates elicited a greater than fourfold
rise in the IgG anti-LPS level in serum in
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Phase 1 and Phase 2 Studies of Salmonella
enterica Serovar Paratyphi A O-Specific Polysaccharide-Tetanus
Toxoid Conjugates in Adults, Teenagers, and 2- to 4-Year-Old
Children in Vietnam
80% of the volunteers.
SPA-TT2 elicited slightly higher, though not statistically
significantly, levels of IgG anti-LPS than did SPA-TT1 in
these age groups. Accordingly, only SPA-TT2 was evaluated
in the 2- to 4-year-old children. On a random basis, one or two
injections were administered 6 weeks apart to the children. No
significant side effects were observed, and the levels of preexisting
anti-LPS in serum were similar in children of all ages. A significant
rise in the IgG anti-LPS titer was elicited by the first injection
(P = 0.0001); a second injection did not elicit a
booster response. Representative sera from all groups had bactericidal
activity that could be adsorbed by S. enterica serovar
Paratyphi A LPS.
*
Corresponding author. Mailing address: National
Institute of Child Health and Human Development, National Institutes of
Health, Bldg. 6, Room 424, Bethesda, MD 20892. Phone: (301) 496-4524. Fax: (301) 402-9108. E-mail: scszu{at}helix.nih.gov.
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»